Apoptosis and nuclear factor-κB: A tale of association and dissociation

Biochemical Pharmacology

Volumn 60, Issue 8, 2000, Pages 1033-1039

  Aggarwal, Bharat B ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Apoptosis; Caspases; NF B; Reactive oxygen intermediates; TNF

Indexed keywords

CYCLOHEXIMIDE; CYTARABINE; ETOPOSIDE; GLUTATHIONE TRANSFERASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEINASE INHIBITOR; PYRROLIDINE DITHIOCARBAMATE; TOSYLPHENYLALANYL CHLOROMETHYL KETONE; TRANSCRIPTION FACTOR; TUMOR NECROSIS FACTOR;

ANIMAL CELL; APOPTOSIS; CANCER THERAPY; CELL DEATH; CYTOTOXICITY; DOSE RESPONSE; DRUG MECHANISM; GENE CONTROL; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVIEW;

EID: 0034668151     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(00)00393-2     Document Type: Article

References (82)

1. Wyllie A., Kerr J., Currie A. Cell death the significance of apoptosis . Int Rev Cytol. 68:1980;251-306.
2. Mukhopadhyay A., Ni J., Zhai Y., Yu G.L., Aggarwal B.B. Identification and characterization of a novel cytokine, THANK, a TNF homologue that activates apoptosis, nuclear factor-kappaB, and c-Jun NH2-terminal kinase. J Biol Chem. 274:1999;15978-15981.
3. Haridas V., Shrivastava A., Su J., Yu G.-L., Ni J., Liu D., Chen S.-F., Ni Y., Ruben S.M., Gentz R., Aggarwal B.B. VEGI, a new member of the TNF family activates nuclear factor-κB and c-Jun N-terminal kinase and modulates cell growth. Oncogene. 18:1999;6496-6504.
4. Rath P.C., Aggarwal B.B. TNF-induced signaling in apoptosis. J Clin Immunol. 19:1999;350-364.
5. Darnay B.G., Aggarwal B.B. Signal transduction by TNF and TNF-related ligands and their receptors. Ann Rheum Dis. 58:1999;S0-S11.
6. Wallach D., Varfolomeev E.E., Malinin N.L., Goltsev Y.V., Kovalenko A.V., Boldin M.P. Tumor necrosis factor receptor and Fas signaling mechanisms. Annu Rev Immunol. 17:1999;331-367.
7. Baichwal V.R., Baeuerle P.A. Activate NF-kappa B or die? Curr Biol. 7:1997;R94-R96.
8. Van Antwerp D.J., Martin S.J., Verma I.M., Green D.R. Inhibition of TNF-induced apoptosis by NF-kappa B. Trends Cell Biol. 8:1998;107-111.
9. Aggarwal B.B., Kohr W.J., Hass P.E., Moffat B., Spencer S.A., Henzel W.J., Bringman T.S., Nedwin G.E., Goeddel D.V., Harkins R.N. Human tumor necrosis factor Production, purification and characterization . J Biol Chem. 260:1985;2345-2354.
10. Wallach D. Preparations of lymphotoxin induce resistance to their own cytotoxic effect. J Immunol. 132:1984;2464-2469.
11. Beg A.A., Baltimore D. An essential role for NF-kappaB in preventing TNF-alpha-induced cell death. Science. 274:1996;782-784.
12. Wang C.Y., Mayo M.W., Baldwin A.S. Jr. TNF- and cancer therapy-induced apoptosis Potentiation by inhibition of NF-kappaB . Science. 274:1996;784-787.
13. Van Antwerp D.J., Martin S.J., Kafri T., Green D.R., Verma I.M. Suppression of TNF-alpha-induced apoptosis by NF-kappaB. Science. 274:1996;787-789.
14. Liu Z.G., Hsu H., Goeddel D.V., Karin M. Dissection of TNF receptor 1 effector functions JNK activation is not linked to apoptosis while NF-kappaB activation prevents cell death . Cell. 87:1996;565-576.
15. Wu M., Lee H., Bellas R.E., Schauer S.L., Arsura M., Katz D., FitzGerald M.J., Rothstein T.L., Sherr D.H., Sonenshein G.E. Inhibition of NF-kappaB/Rel induces apoptosis of murine B cells. EMBO J. 15:1996;4682-4690.
16. Wang C.Y., Cusack J.C. Jr, Liu R., Baldwin A.S. Jr. Control of inducible chemoresistance Enhanced anti-tumor therapy through increased apoptosis by inhibition of NF-kappaB . Nat Med. 5:1999;412-417.
17. Qin J.Z., Chaturvedi V., Denning M.F., Choubey D., Diaz M.O., Nickoloff B.J. Role of NF-kappaB in the apoptotic-resistant phenotype of keratinocytes. J Biol Chem. 274:1999;37957-37964.
18. Zen K., Karsan A., Stempien-Otero A., Yee E., Tupper J., Li X., Eunson T., Kay M.A., Wilson C.B., Winn R.K., Harlan J.M. NF-kappaB activation is required for human endothelial survival during exposure to tumor necrosis factor-alpha but not to interleukin-1beta or lipopolysaccharide. J Biol Chem. 274:1999;28808-28815.
19. Stehlik C., de Martin R., Kumabashiri I., Schmid J.A., Binder B.R., Lipp J. Nuclear factor (NF)-kappaB-regulated X-chromosome-linked iap gene expression protects endothelial cells from tumor necrosis factor alpha-induced apoptosis. J Exp Med. 188:1998;211-216.
20. Liu R.Y., Fan C., Olashaw N.E., Wang X., Zuckerman K.S. Tumor necrosis factor-alpha-induced proliferation of human Mo7e leukemic cells occurs via activation of nuclear factor kappaB transcription factor. J Biol Chem. 274:1999;13877-13885.
21. Delic J., Masdehors P., Omura S., Cosset J.M., Dumont J., Binet J.L., Magdelenat H. The proteasome inhibitor lactacystin induces apoptosis and sensitizes chemo- and radioresistant human chronic lymphocytic leukaemia lymphocytes to TNF-alpha-initiated apoptosis. Br J Cancer. 77:1998;1103-1107.
22. Jeremias I., Kupatt C., Baumann B., Herr I., Wirth T., Debatin K.M. Inhibition of nuclear factor kappaB activation attenuates apoptosis resistance in lymphoid cells. Blood. 91:1998;4624-4631.
23. Giri D.K., Aggarwal B.B. Constitutive activation of NF-kappaB causes resistance to apoptosis in human cutaneous T cell lymphoma HuT-78 cells. Autocrine role of tumor necrosis factor and reactive oxygen intermediates. J Biol Chem. 273:1998;14008-14014.
24. Xu Y., Bialik S., Jones B.E., Iimuro Y., Kitsis R.N., Srinivasan A., Brenner D.A., Czaja M.J. NF-kappaB inactivation converts a hepatocyte cell line TNF-alpha response from proliferation to apoptosis. Am J Physiol. 275:1998;C1058-C1066.
25. Bakker T.R., Reed D., Renno T., Jongeneel C.V. Efficient adenoviral transfer of NF-kappaB inhibitor sensitizes melanoma to tumor necrosis factor-mediated apoptosis. Int J Cancer. 80:1999;320-323.
26. Sumitomo M., Tachibana M., Nakashima J., Murai M., Miyajima A., Kimura F., Hayakawa M., Nakamura H. An essential role for nuclear factor kappa B in preventing TNF-alpha-induced cell death in prostate cancer cells. J Urol. 161:1999;674-679.
27. Soler A.P., Marano C.W., Bryans M., Miller R.D., Garulacan L.A., Mauldin S.K., Stamato T.D., Mullin J.M. Activation of NF-kappaB is necessary for the restoration of the barrier function of an epithelium undergoing TNF-alpha-induced apoptosis. Eur J Cell Biol. 78:1999;56-66.
28. Sugiyama H., Savill J.S., Kitamura M., Zhao L., Stylianou E. Selective sensitization to tumor necrosis factor-alpha-induced apoptosis by blockade of NF-kappaB in primary glomerular mesangial cells. J Biol Chem. 274:1999;19532-19537.
29. McDade T.P., Perugini R.A., Vittimberga F.J. Jr, Carrigan R.C., Callery M.P. Salicylates inhibit NF-kappaB activation and enhance TNF-alpha-induced apoptosis in human pancreatic cancer cells. J Surg Res. 83:1999;56-61.
30. Javelaud D., Wietzerbin J., Delattre O., Besancon F. Induction of p21Waf1/Cip1 by TNFalpha requires NF-kappaB activity and antagonizes apoptosis in Ewing tumor cells. Oncogene. 19:2000;61-68.
31. Duffey D.C., Chen Z., Dong G., Ondrey F.G., Wolf J.S., Brown K., Siebenlist U., Van Waes C. Expression of a dominant-negative mutant inhibitor-kappaBalpha of nuclear factor-kappaB in human head and neck squamous cell carcinoma inhibits survival, proinflammatory cytokine expression, and tumor growth in vivo. Cancer Res. 59:1999;3468-3474.
32. Diaz-Meco M.T., Lallena M.J., Monjas A., Frutos S., Moscat J. Inactivation of the inhibitory kappaB protein kinase/nuclear factor kappaB pathway by Par-4 expression potentiates tumor necrosis factor alpha-induced apoptosis. J Biol Chem. 274:1999;19606-19612.
33. Ruckdeschel K., Harb S., Roggenkamp A., Hornef M., Zumbihl R., Kohler S., Heesemann J., Rouot B. Yersinia enterocolitica impairs activation of transcription factor NF-kappaB Involvement in the induction of programmed cell death and in the suppression of the macrophage tumor necrosis factor alpha production . J Exp Med. 187:1998;1069-1079.
34. Manna S.K., Aggarwal B.B. Lipopolysaccharide inhibits TNF-induced apoptosis Role of nuclear factor-kappaB activation and reactive oxygen intermediates . J Immunol. 162:1999;1510-1518.
35. Ray R.B., Meyer K., Steele R., Shrivastava A., Aggarwal B.B., Ray R. Inhibition of tumor necrosis factor-mediated apoptosis by hepatitis C virus core protein. J Biol Chem. 273:1998;2256-2259.
36. Marusawa H., Hijikata M., Chiba T., Shimotohno K. Hepatitis C virus core protein inhibits Fas- and tumor necrosis factor alpha-mediated apoptosis via NF-kappaB activation. J Virol. 73:1999;4713-4720.
37. Johannes F.J., Horn J., Link G., Haas E., Siemienski K., Wajant H., Pfizenmaier K. Protein kinase Cmu downregulation of tumor-necrosis-factor-induced apoptosis correlates with enhanced expression of nuclear-factor-kappaB-dependent protective genes. Eur J Biochem. 257:1998;47-54.
38. Shao R., Karunagaran D., Zhou B.P., Li K., Lo S.S., Deng J., Chiao P., Hung M.C. Inhibition of nuclear factor-kappaB activity is involved in E1A-mediated sensitization of radiation-induced apoptosis. J Biol Chem. 272:1997;32739-32742.
39. Chu Z.L., McKinsey T.A., Liu L., Gentry J.J., Malim M.H., Ballard D.W. Suppression of tumor necrosis factor-induced cell death by inhibitor of apoptosis c-IAP2 is under NF-kappaB control. Proc Natl Acad Sci USA. 94:1997;10057-10062.
40. Wang C.Y., Mayo M.W., Korneluk R.G., Goeddel D.V., Baldwin A.S. Jr. NF-kappaB antiapoptosis Induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation . Science. 281:1998;1680-1683.
41. Manna S., Zhang H.J., Yan T., Oberley L.W., Aggarwal B.B. Overexpression of manganese superoxide dismutase suppresses tumor necrosis factor-induced apoptosis and activation of nuclear transcription factor-κB and activated protein-1. J Biol Chem. 273:1998;13245-13254.
42. Bertrand F., Desbois-Mouthon C., Cadoret A., Prunier C., Robin H., Capeau J., Atfi A., Cherqui G. Insulin antiapoptotic signaling involves insulin activation of the nuclear factor kappaB-dependent survival genes encoding tumor necrosis factor receptor-associated factor 2 and manganese-superoxide dismutase. J Biol Chem. 274:1999;30596-30602.
43. Opipari A.W. Jr, Boguski M.S., Dixit V.M. The A20 cDNA induced by tumor necrosis factor alpha encodes a novel type of zinc finger protein. J Biol Chem. 265:1990;14705-14708.
44. Krikos A., Laherty C.D., Dixit V.M. Transcriptional activation of the tumor necrosis factor alpha-inducible zinc finger protein, A20, is mediated by kappa B elements. J Biol Chem. 267:1992;17971-17976.
45. Opipari A.W. Jr, Hu H.M., Yabkowitz R., Dixit V.M. The A20 zinc finger protein protects cells from tumor necrosis factor cytotoxicity. J Biol Chem. 267:1992;12424-12427.
46. Guttridge D.C., Albanese C., Reuther J.Y., Pestell R.G., Baldwin A.S. Jr. NF-kappaB controls cell growth and differentiation through transcriptional regulation of cyclin D1. Mol Cell Biol. 19:1999;5785-5799.
47. Hinz M., Krappmann D., Eichten A., Heder A., Scheidereit C., Strauss M. NF-kappaB function in growth control Regulation of cyclin D1 expression and G0/G1-to-S-phase transition . Mol Cell Biol. 19:1999;2690-2698.
48. Zong W.X., Edelstein L.C., Chen C., Bash J., Gelinas C. The prosurvival Bcl-2 homolog Bfl-1/A1 is a direct transcriptional target of NF-kappaB that blocks TNF alpha-induced apoptosis. Genes Dev. 13:1999;382-387.
49. de Moissac D., Mustapha S., Greenberg A.H., Kirshenbaum L.A. Bcl-2 activates the transcription factor NfkappaB through the degradation of the cytoplasmic inhibitor Ikappa B alpha. J Biol Chem. 273:1998;23946-23951.
50. Romashkova J.A., Makarov S.S. NF-kappaB is a target of AKT in anti-apoptotic PDGF signalling. Nature. 401:1999;86-90.
51. Natoli G., Costanzo A., Guido F., Moretti F., Bernardo A., Burgio V.L., Agresti C., Levrero M. Nuclear factor kB-independent cytoprotective pathways originating at tumor necrosis factor receptor-associated factor 2. J Biol Chem. 273:1998;31262-31272.
52. Levkau B., Scatena M., Giachelli C.M., Ross R., Raines E.W. Apoptosis overrides survival signals through a caspase-mediated dominant-negative NF-kappa B loop. Nat Cell Biol. 1:1999;227-233.
53. Reuther J.Y., Baldwin A.S. Jr. Apoptosis promotes a caspase-induced amino-terminal truncation of IkappaBalpha that functions as a stable inhibitor of NF-kappaB. J Biol Chem. 274:1999;20664-20670.
54. Ravi R., Bedi A., Fuchs E.J., Bedi A. CD95 (Fas)-induced caspase-mediated proteolysis of NF-kappaB. Cancer Res. 58:1998;882-886.
55. Kitajima I., Soejima Y., Takasaki I., Beppu H., Tokioka T., Maruyama I. Ceramide-induced nuclear translocation of NF-kappa B is a potential mediator of the apoptotic response to TNF-alpha in murine clonal osteoblasts. Bone. 19:1996;263-270.
56. Hu X., Tang M., Fisher A.B., Olashaw N., Zuckerman K.S. TNF-alpha-induced growth suppression of CD34+ myeloid leukemic cell lines signals through TNF receptor type I and is associated with NF-kappa B activation. J Immunol. 163:1999;3106-3115.
57. Li Y., Zhang W., Mantell L.L., Kazzaz J.A., Fein A.M., Horowitz S. Nuclear factor-kappaB is activated by hyperoxia but does not protect from cell death. J Biol Chem. 272:1997;20646-20649.
58. Grey S.T., Arvelo M.B., Hasenkamp W., Bach F.H., Ferran C. A20 inhibits cytokine-induced apoptosis and nuclear factor kappaB-dependent gene activation in islets. J Exp Med. 190:1999;1135-1146.
59. Bessho R., Matsubara K., Kubota M., Kuwakado K., Hirota H., Wakazono Y., Lin Y.W., Okuda A., Kawai M., Nishikomori R., et al. Pyrrolidine dithiocarbamate, a potent inhibitor of nuclear factor kappa B (NF-kappa B) activation, prevents apoptosis in human promyelocytic leukemia HL-60 cells and thymocytes. Biochem Pharmacol. 48:1994;1883-1889.
60. Vollgraf U., Wegner M., Richter-Landsberg C. Activation of AP-1 and nuclear factor-kappaB transcription factors is involved in hydrogen peroxide-induced apoptotic cell death of oligodendrocytes. J Neurochem. 73:1999;2501-2509.
61. Dumont A., Hehner S.P., Hofmann T.G., Ueffing M., Droge W., Schmitz M.L. Hydrogen peroxide-induced apoptosis is CD95-independent, requires the release of mitochondria-derived reactive oxygen species and the activation of NF-kappaB. Oncogene. 18:1999;747-757.
62. Lin K.I., Lee S.H., Narayanan R., Baraban J.M., Hardwick J.M., Ratan R.R. Thiol agents and Bcl-2 identify an alphavirus-induced apoptotic pathway that requires activation of the transcription factor NF-kappa B. J Cell Biol. 131:1995;1149-1161.
63. 2+ reperfusion injury of cultured astrocytes Roles of reactive oxygen species and NF-kappaB activation . Eur J Neurosci. 11:1999;4204-4212.
64. Schneider A., Martin-Villalba A., Weih F., Vogel J., Wirth T., Schwaninger M. NF-kappaB is activated and promotes cell death in focal cerebral ischemia. Nat Med. 5:1999;554-559.
65. Lin K.I., DiDonato J.A., Hoffmann A., Hardwick J.M., Ratan R.R. Suppression of steady-state, but not stimulus-induced NF-kappaB activity inhibits alphavirus-induced apoptosis. J Cell Biol. 141:1998;1479-1487.
66. Nakai M., Qin Z.H., Chen J.F., Wang Y., Chase T.N. Kainic acid-induced apoptosis in rat striatum is associated with nuclear factor-kappaB activation. J Neurochem. 74:2000;647-658.
67. Bellas R.E., Sonenshein G.E. Nuclear factor kappaB cooperates with c-Myc in promoting murine hepatocyte survival in a manner independent of p53 tumor suppressor function. Cell Growth Differ. 10:1999;287-294.
68. Cai Z., Korner M., Tarantino N., Chouaib S. IkappaB alpha overexpression in human breast carcinoma MCF7 cells inhibits nuclear factor-kappaB activation but not tumor necrosis factor-alpha-induced apoptosis. J Biol Chem. 272:1997;96-101.
69. Ferran C., Stroka D.M., Badrichani A.Z., Cooper J.T., Wrighton C.J., Soares M., Grey S.T., Bach F.H. A20 inhibits NF-kappaB activation in endothelial cells without sensitizing to tumor necrosis factor-mediated apoptosis. Blood. 91:1998;2249-2258.
70. Marinovich M., Viviani B., Corsini E., Ghilardi F., Galli C.L. NF-kappaB activation by triphenyltin triggers apoptosis in HL-60 cells. Exp Cell Res. 226:1996;98-104.
71. Usami I., Kubota M., Bessho R., Kataoka A., Koishi S., Watanabe K., Sawada M., Lin Y.W., Akiyama Y., Furusho K. Role of protein tyrosine phosphorylation in etoposide-induced apoptosis and NF-kappa B activation. Biochem Pharmacol. 55:1998;185-191.
72. Ting A.T., Pimentel-Muinos F.X., Seed B. RIP mediates tumor necrosis factor receptor 1 activation of NF-kappaB but not Fas/APO-1-initiated apoptosis. EMBO J. 15:1996;6189-6196.
73. Kelliher M.A., Grimm S., Ishida Y., Kuo F., Stanger B.Z., Leder P. The death domain kinase RIP mediates the TNF-induced NF-kappaB signal. Immunity. 8:1998;297-303.
74. McCarthy J.V., Ni J., Dixit V.M. RIP2 is a novel NF-kappaB-activating and cell death-inducing kinase. J Biol Chem. 273:1998;16968-16975.
75. Pazdernik N.J., Donner D.B., Goebl M.G., Harrington M.A. Mouse receptor interacting protein 3 does not contain a caspase-recruiting or a death domain but induces apoptosis and activates NF-kappaB. Mol Cell Biol. 19:1999;6500-6508.
76. Inohara N., Koseki T., del Peso L., Hu Y., Yee C., Chen S., Carrio R., Merino J., Liu D., Ni J., Nunez G. Nod1, an Apaf-1-like activator of caspase-9 and nuclear factor-kappaB. J Biol Chem. 274:1999;14560-14567.
77. Srinivasula S.M., Ahmad M., Lin J.H., Poyet J.L., Fernandes-Alnemri T., Tsichlis P.N., Alnemri E.S. CLAP, a novel caspase recruitment domain-containing protein in the tumor necrosis factor receptor pathway, regulates NF-kappaB activation and apoptosis. J Biol Chem. 274:1999;17946-17954.
78. Li Z.W., Chu W., Hu Y., Delhase M., Deerinck T., Ellisman M., Johnson R., Karin M. The IKKbeta subunit of IkappaB kinase (IKK) is essential for nuclear factor kappaB activation and prevention of apoptosis. J Exp Med. 189:1999;1839-1845.
79. Manna S.K., Kuo M.T., Aggarwal B.B. Overexpression of γ-glutamylcysteine synthetase abolishes tumor necrosis factor-induced apoptosis and activation of nuclear transcription factor-kappa B and activator protein-1. Oncogene. 18:1999;4371-4382.
80. Badrichani A.Z., Stroka D.M., Bilbao G., Curiel D.T., Bach F.H., Ferran C. Bcl-2 and Bcl-XL serve an anti-inflammatory function in endothelial cells through inhibition of NF-kappaB. J Clin Invest. 103:1999;543-553.
81. van Hogerlinden M., Rozell B.L., Ahrlund-Richter L., Toftgard R. Squamous cell carcinomas and increased apoptosis in skin with inhibited Rel/nuclear factor-kappaB signaling. Cancer Res. 59:1999;3299-3303.
82. Estrov Z., Manna S.K., Harris D. Van Q, Kantarjian HM, Talpaz M and Aggarwal BB, Phenylarsine oxide (PAO) blocks interleukin (IL)-1β-induced activation of the nuclear transcription factor NF-κB, inhibits proliferation, and induces apoptosis of acute myelogenous leukemia (AML) cells. Blood. 95:1999;2844-2853.